(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)], has been approved by the European Commission for the treatment of peanut allergy in the European … Read the full press release →
Posted in European Union, Food & Beverage, Healthcare, News, Pharma & Biotech, Switzerland
Tagged Aimmune Therapeutics, Andrew Oxtoby, ARTEMIS, EC, EU, European Commission, European Union, food allergies, Greg Behar, Nestlé Health Science, OIT, oral desensitization therapy, oral immunotherapy, PALFORZIA, PALISADE, peanut allergy, peanut protein, SwissMedic, treatment of peanut allergy